Literature DB >> 4399660

Separation and spectrofluorometric assay of the -adrenergic blocker sotalol from blood and urine.

E R Garrett, K Schnelle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4399660     DOI： 10.1002/jps.2600600607

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  13 in total

1.  Observations on the efficacy and pharmacokinetics of sotalol after oral administration.

Authors:  H C Brown; S G Carruthers; J G Kelly; D G McDevitt; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

2.  Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.

Authors:  W J Leahey; J D Neill; M P Varma; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1980-06       Impact factor: 2.953

3.  Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.

Authors:  H I Pirttiaho; E A Sotaniemi; R O Pelkonen; U Pitkänen; M Anttila; H Sundqvist
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

4.  The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.

Authors:  T B Tjandramaga; R Verbeeck; J Thomas; R Verbesselt; R Verberckmoes; P J Schepper
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

5.  Stereospecific high-performance liquid chromatographic assay of sotalol in plasma.

Authors:  R A Carr; R T Foster; N H Bhanji
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

6.  Comparison of once and twice daily administration of sotalol in the treatment of hypertension.

Authors:  I Parvinen; E Paukkala
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

7.  Fatal sotalol poisoning.

Authors:  M Montagna; A Groppi
Journal:  Arch Toxicol       Date:  1980-01       Impact factor: 5.153

8.  Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency.

Authors:  G Berglund; R Descamps; J A Thomis
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

9.  Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.

Authors:  P H Hinderling; O Schmidlin; J K Seydel
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

10.  Pharmacokinetics of sotalol during pregnancy.

Authors:  M F O'Hare; W Leahey; G A Murnaghan; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.